Walker Neal has filed 74 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 274800 shares of Aclaris Therapeutics, Inc. ($ACRS) on February 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | CEO | A | Restricted Stock Units | 274800 | $0.00 | 274,800.0000 | 122,564,741 | 9999.99% | 0.22% |
| Feb. 2, 2026 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | CEO | A | Employee Stock Option (Right to Buy) | 961700 | $0.00 | 961,700.0000 | 122,564,741 | 9999.99% | 0.78% |
| Feb. 3, 2026 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | CEO | M | Restricted Stock Units | 63475 | $0.00 | 190,425.0000 | 122,564,741 | 25.00% | 0.05% |
| Feb. 3, 2026 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | CEO | M | Common Stock | 63475 | $0.00 | 1,562,497.0000 | 122,564,741 | 4.23% | 0.05% |
| Feb. 3, 2026 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | CEO | F | Common Stock | 18611 | $3.47 | 1,543,886.0000 | 122,564,741 | 1.19% | 0.02% |
| Jan. 2, 2026 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | CEO | M | Restricted Stock Units | 29150 | $0.00 | 30,034.0000 | 122,564,741 | 49.25% | 0.02% |
| Jan. 2, 2026 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | CEO | M | Common Stock | 29150 | $0.00 | 1,508,974.0000 | 122,564,741 | 1.97% | 0.02% |
| Jan. 2, 2026 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | CEO | F | Common Stock | 9952 | $2.88 | 1,499,022.0000 | 122,564,741 | 0.66% | 0.01% |
| June 10, 2025 | Aldeyra Therapeutics, Inc. | $ALDX | Walker Neal | Not found | A | Stock Option (Right to Buy) | 2413 | $0.00 | 2,413.0000 | 59,708,654 | 9999.99% | 0.00% |
| June 10, 2025 | Aldeyra Therapeutics, Inc. | $ALDX | Walker Neal | Not found | A | Stock Option (Right to Buy) | 62728 | $0.00 | 62,728.0000 | 59,708,654 | 9999.99% | 0.11% |
| May 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | CEO | F | Common Stock | 2975 | $1.38 | 1,479,824.0000 | 122,390,303 | 0.20% | 0.00% |
| May 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | CEO | M | Common Stock | 9467 | $0.00 | 1,482,799.0000 | 122,390,303 | 0.64% | 0.01% |
| May 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | CEO | M | Restricted Stock Units | 9467 | $0.00 | 0.0000 | 122,390,303 | 100.00% | 0.01% |
| April 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | CEO | F | Common Stock | 3042 | $1.48 | 1,473,332.0000 | 122,390,303 | 0.21% | 0.00% |
| April 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | CEO | M | Restricted Stock Units | 9467 | $0.00 | 9,467.0000 | 122,390,303 | 50.00% | 0.01% |
| April 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | CEO | M | Common Stock | 9467 | $0.00 | 1,476,374.0000 | 122,390,303 | 0.65% | 0.01% |
| March 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | CEO | M | Common Stock | 9466 | $0.00 | 1,470,184.0000 | 77,296,665 | 0.65% | 0.01% |
| March 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | CEO | F | Common Stock | 3277 | $1.99 | 1,466,907.0000 | 77,296,665 | 0.22% | 0.00% |
| March 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | CEO | M | Restricted Stock Units | 9466 | $0.00 | 18,934.0000 | 77,296,665 | 33.33% | 0.01% |
| Feb. 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | M | Common Stock | 9467 | $0.00 | 1,464,277.0000 | 77,296,665 | 0.65% | 0.01% |
| Feb. 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | F | Common Stock | 3559 | $2.48 | 1,460,718.0000 | 77,296,665 | 0.24% | 0.00% |
| Feb. 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | M | Restricted Stock Units | 9467 | $0.00 | 28,400.0000 | 77,296,665 | 25.00% | 0.01% |
| Feb. 3, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | A | Restricted Stock Units | 253900 | $0.00 | 253,900.0000 | 77,296,665 | 9999.99% | 0.33% |
| Feb. 3, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | A | Employee Stock Option (Right to Buy) | 888800 | $0.00 | 888,800.0000 | 77,296,665 | 9999.99% | 1.15% |
| Jan. 2, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | M | Restricted Stock Units | 29149 | $0.00 | 59,184.0000 | 77,296,665 | 33.00% | 0.04% |
| Jan. 2, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | A | Restricted Stock Units | 88333 | $0.00 | 88,333.0000 | 77,296,665 | 9999.99% | 0.11% |
| Jan. 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | M | Restricted Stock Units | 9467 | $0.00 | 37,867.0000 | 77,296,665 | 20.00% | 0.01% |
| Jan. 2, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | F | Common Stock | 13532 | $2.48 | 1,454,810.0000 | 77,296,665 | 0.92% | 0.02% |
| Jan. 2, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | M | Common Stock | 29149 | $0.00 | 1,468,342.0000 | 77,296,665 | 2.03% | 0.04% |
| Jan. 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | F | Common Stock | 3904 | $2.48 | 1,439,193.0000 | 77,296,665 | 0.27% | 0.01% |
| Jan. 1, 2025 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | M | Common Stock | 9467 | $0.00 | 1,443,097.0000 | 77,296,665 | 0.66% | 0.01% |
| Dec. 4, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | M | Common Stock | 118840 | $1.52 | 1,501,973.0000 | 71,381,731 | 8.59% | 0.17% |
| Dec. 4, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | M | Employee Stock Option (right to buy) | 118840 | $0.00 | 0.0000 | 71,381,731 | 100.00% | 0.17% |
| Dec. 4, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | F | Common Stock | 68343 | $3.76 | 1,433,630.0000 | 71,381,731 | 4.55% | 0.10% |
| Dec. 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | M | Restricted Stock Units | 9466 | $0.00 | 47,334.0000 | 71,381,731 | 16.67% | 0.01% |
| Dec. 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | M | Common Stock | 9466 | $0.00 | 1,385,854.0000 | 71,381,731 | 0.69% | 0.01% |
| Dec. 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM CEO | F | Common Stock | 2721 | $4.07 | 1,383,133.0000 | 71,381,731 | 0.20% | 0.00% |
| Nov. 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Restricted Stock Units | 9467 | $0.00 | 56,800.0000 | 71,381,731 | 14.29% | 0.01% |
| Nov. 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | F | Common Stock | 2721 | $2.09 | 1,376,388.0000 | 71,381,731 | 0.20% | 0.00% |
| Nov. 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Common Stock | 9467 | $0.00 | 1,379,109.0000 | 71,381,731 | 0.69% | 0.01% |
| Oct. 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Common Stock | 9467 | $0.00 | 1,372,364.0000 | 71,381,731 | 0.69% | 0.01% |
| Oct. 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | F | Common Stock | 2722 | $1.18 | 1,369,642.0000 | 71,381,731 | 0.20% | 0.00% |
| Oct. 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Restricted Stock Units | 9467 | $0.00 | 66,267.0000 | 71,381,731 | 12.50% | 0.01% |
| Sept. 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Common Stock | 9466 | $0.00 | 1,365,619.0000 | 71,291,400 | 0.70% | 0.01% |
| Sept. 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | F | Common Stock | 2722 | $1.18 | 1,362,897.0000 | 71,291,400 | 0.20% | 0.00% |
| Sept. 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Restricted Stock Units | 9466 | $0.00 | 75,734.0000 | 71,291,400 | 11.11% | 0.01% |
| Aug. 9, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Common Stock | 43548 | $0.72 | 1,356,153.0000 | 71,291,400 | 3.32% | 0.06% |
| Aug. 9, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Employee Stock Option (right to buy) | 43548 | $0.00 | 0.0000 | 71,291,400 | 100.00% | 0.06% |
| Aug. 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Restricted Stock Units | 9467 | $0.00 | 85,200.0000 | 71,291,400 | 10.00% | 0.01% |
| Aug. 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Common Stock | 9467 | $0.00 | 1,315,327.0000 | 71,291,400 | 0.72% | 0.01% |
| Aug. 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | F | Common Stock | 2722 | $1.32 | 1,312,605.0000 | 71,291,400 | 0.21% | 0.00% |
| July 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Common Stock | 9467 | $0.00 | 1,308,582.0000 | 71,291,400 | 0.73% | 0.01% |
| July 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | F | Common Stock | 2722 | $1.15 | 1,305,860.0000 | 71,291,400 | 0.21% | 0.00% |
| July 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Restricted Stock Units | 9467 | $0.00 | 94,667.0000 | 71,291,400 | 9.09% | 0.01% |
| June 4, 2024 | Aldeyra Therapeutics, Inc. | $ALDX | Walker Neal | Not found | A | Stock Option (Right to Buy) | 40282 | $0.00 | 40,282.0000 | 0 | 9999.99% | 0.00% |
| June 4, 2024 | Aldeyra Therapeutics, Inc. | $ALDX | Walker Neal | Not found | A | Stock Option (Right to Buy) | 1736 | $0.00 | 1,736.0000 | 0 | 9999.99% | 0.00% |
| June 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Common Stock | 9466 | $0.00 | 1,301,837.0000 | 71,074,858 | 0.73% | 0.01% |
| June 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | F | Common Stock | 2722 | $1.03 | 1,299,115.0000 | 71,074,858 | 0.21% | 0.00% |
| June 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Restricted Stock Units | 9466 | $0.00 | 104,134.0000 | 71,074,858 | 8.33% | 0.01% |
| May 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Restricted Stock Units | 9467 | $0.00 | 113,600.0000 | 71,074,858 | 7.69% | 0.01% |
| May 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Common Stock | 9467 | $0.00 | 1,295,155.0000 | 71,074,858 | 0.74% | 0.01% |
| May 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | F | Common Stock | 2784 | $1.26 | 1,292,371.0000 | 71,074,858 | 0.21% | 0.00% |
| April 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Restricted Stock Units | 9467 | $0.00 | 123,067.0000 | 71,074,858 | 7.14% | 0.01% |
| April 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | M | Common Stock | 9467 | $0.00 | 1,288,912.0000 | 71,074,858 | 0.74% | 0.01% |
| April 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | INTERIM PRESIDENT AND CEO | F | Common Stock | 3224 | $1.26 | 1,285,688.0000 | 71,074,858 | 0.25% | 0.00% |
| March 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | Interim President and CEO | M | Restricted Stock Units | 9466 | $0.00 | 132,534.0000 | 69,808,855 | 6.67% | 0.01% |
| March 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | Interim President and CEO | M | Common Stock | 9466 | $0.00 | 1,282,668.0000 | 69,808,855 | 0.74% | 0.01% |
| March 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | Interim President and CEO | F | Common Stock | 3223 | $1.24 | 1,279,445.0000 | 69,808,855 | 0.25% | 0.00% |
| Feb. 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | Interim CEO | A | Restricted Stock Units | 142000 | $0.00 | 142,000.0000 | 69,808,855 | 9999.99% | 0.20% |
| Feb. 1, 2024 | Aclaris Therapeutics, Inc. | $ACRS | Walker Neal | Interim CEO | A | Stock Option (Right to Buy) | 497000 | $0.00 | 497,000.0000 | 69,808,855 | 9999.99% | 0.71% |
| Aug. 22, 2023 | Aldeyra Therapeutics, Inc. | $ALDX | Walker Neal | Not found | M | Stock Option (Right to Buy) | 9604 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 22, 2023 | Aldeyra Therapeutics, Inc. | $ALDX | Walker Neal | Not found | M | Common Stock | 9604 | $0.55 | 15,854.0000 | 0 | 153.66% | 0.00% |
| June 30, 2023 | Aldeyra Therapeutics, Inc. | $ALDX | Walker Neal | Not found | A | Stock Option (Right to Buy) | 21222 | $0.00 | 21,222.0000 | 0 | 9999.99% | 0.00% |
| June 30, 2023 | Aldeyra Therapeutics, Inc. | $ALDX | Walker Neal | Not found | A | Stock Option (Right to Buy) | 915 | $0.00 | 915.0000 | 0 | 9999.99% | 0.00% |